science
Sciencedaily
2026-07-10
New Weight Loss Pill Outperforms Oral Ozempic in Trial
A new daily weight-loss pill, orforglipron, showed superior results in weight loss and blood sugar control compared to oral semaglutide for type 2 diabetes patients. The pill offers a convenient, potentially more affordable alternative to injectable medications.